Skip to main content

Effect of PD I administration on dopamine receptors mRNAs expression in the lesioned striatum of PD rat model

Summary

To study the effect of PD I administration on dopamine receptors (DR1, DR2) mRNAs expression in the lesioned striatum of the PD rat model and confirm if PD I has the effect of dopamine receptor agonist. The PD rats with unilateral 6-hydroxydopamine lesioned were administrated with PD I, L-dopa methyl/benserazide, L-dopa methyl/benserazide/PD I, normal saline respectively for 4 weeks and their behavioral changes were observed. Then the rats were sacrificed and RT-PCR technique was used to detect changes of dopamine receptors (DR1, DR2) mRNAs expression in the ipsilateral striatum 1 day after the last treatment. The results showed that treatment with PD I plus L-dopa resulted in a stable contralateral rotation behavior; treatment with L-dopa resulted in a progressively increased contralateral rotation behavior. Rotation behavior induced by anhydromorphine decreased with PD I or PD I plus L-dopa treatment. Treatment With L-dopa or PD I plus L-dopa, up-regulation of DR1 mRNA and down-regulation of DR2 mRNA were observed in the ipsilateral striatum which were more obvious than that treated with PD I or vehicle (P<0.05). It was concluded that long-term treatment with PD I could alleviate the behavior of PD rats. PD I had no apparent effect on the dopamine receptors (DR1, DR2) mRNAs expression in the ipsilateral striatum and the PD I has no agonist effect on dopamine receptors.

This is a preview of subscription content, access via your institution.

References

  1. Cao X B, Sun S G, Liu H Jet al. The experiment research of Parkinson's disease with Chinese herb treatment. J Chinese rehabilitation, 2001, 16(4): 391

    Google Scholar 

  2. Flores G, Liang J J, Sierra Aet al. Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography. Neuroscience, 1999, 91(2): 549

    PubMed  Article  CAS  Google Scholar 

  3. Hwang W J, Yao W J, Wey S Pet al. Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation. Eur Neurol, 2002, 47(2): 113

    PubMed  Article  CAS  Google Scholar 

  4. Antonini A, Schwarz J, Oertel W Het al. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride. Mov Disord, 1997, 12(1): 33

    PubMed  Article  CAS  Google Scholar 

  5. Turjanski N, Lees A J, Brooks D J. In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias. Neurology, 1997, 49(3): 717

    PubMed  CAS  Google Scholar 

  6. Opacka-Juffry J, Ashworth S, Ahier R Get al. Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET. J Neural Transm, 1998, 105(4–5): 349

    PubMed  Article  CAS  Google Scholar 

  7. Muriel M P, Orieux G, Hirsch E C. Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats. Mov Disord, 2002, 17(6): 1174

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Additional information

YANG Mei, female, born in 1975, M. D., Ph. D.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mei, Y., Shenggang, S. & Xuebing, C. Effect of PD I administration on dopamine receptors mRNAs expression in the lesioned striatum of PD rat model. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 25, 645–647 (2005). https://doi.org/10.1007/BF02896159

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02896159

Key words

  • Parkinson's disease
  • 6-hydroxydopamine
  • dopamine receptor